These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15821729)

  • 21. Metabolic engineering of Escherichia coli for enhanced production of succinic acid, based on genome comparison and in silico gene knockout simulation.
    Lee SJ; Lee DY; Kim TY; Kim BH; Lee J; Lee SY
    Appl Environ Microbiol; 2005 Dec; 71(12):7880-7. PubMed ID: 16332763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic high-yield production of human secreted proteins in Escherichia coli.
    Dai X; Chen Q; Lian M; Zhou Y; Zhou M; Lu S; Chen Y; Luo J; Gu X; Jiang Y; Luo M; Zheng X
    Biochem Biophys Res Commun; 2005 Jul; 332(2):593-601. PubMed ID: 15896719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-dimensional gene target search for improving lycopene biosynthesis in Escherichia coli.
    Jin YS; Stephanopoulos G
    Metab Eng; 2007 Jul; 9(4):337-47. PubMed ID: 17509919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the overproduction of amino acids using the bilevel optimization framework OptKnock.
    Pharkya P; Burgard AP; Maranas CD
    Biotechnol Bioeng; 2003 Dec; 84(7):887-99. PubMed ID: 14708128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic engineering of Escherichia coli: construction and characterization of a gltA (citrate synthase) knockout mutant.
    Vandedrinck S; Deschamps G; Sablon E; Vandamme EJ
    Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet; 2001; 66(3a):333-6. PubMed ID: 15954614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precursor balancing for metabolic engineering of lycopene production in Escherichia coli.
    Farmer WR; Liao JC
    Biotechnol Prog; 2001; 17(1):57-61. PubMed ID: 11170480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strain-dependent carotenoid productions in metabolically engineered Escherichia coli.
    Chae HS; Kim KH; Kim SC; Lee PC
    Appl Biochem Biotechnol; 2010 Dec; 162(8):2333-44. PubMed ID: 20559754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Replicon-free and markerless methods for genomic insertion of DNAs in phage attachment sites and controlled expression of chromosomal genes in Escherichia coli.
    Chiang CJ; Chen PT; Chao YP
    Biotechnol Bioeng; 2008 Dec; 101(5):985-95. PubMed ID: 18553504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of culture conditions for a synthetic gene expression in Escherichia coli using response surface methodology: the case of human interferon beta.
    Maldonado LM; Hernández VE; Rivero EM; Barba de la Rosa AP; Flores JL; Acevedo LG; De León Rodríguez A
    Biomol Eng; 2007 Jun; 24(2):217-22. PubMed ID: 17126075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel knockout and up-regulated targets for improving isoprenoid production in E. coli.
    Wang JF; Meng HL; Xiong ZQ; Zhang SL; Wang Y
    Biotechnol Lett; 2014 May; 36(5):1021-7. PubMed ID: 24658737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineering the lycopene synthetic pathway in E. coli by comparison of the carotenoid genes of Pantoea agglomerans and Pantoea ananatis.
    Yoon SH; Kim JE; Lee SH; Park HM; Choi MS; Kim JY; Lee SH; Shin YC; Keasling JD; Kim SW
    Appl Microbiol Biotechnol; 2007 Feb; 74(1):131-9. PubMed ID: 17115209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of mevalonate by a metabolically-engineered Escherichia coli.
    Tabata K; Hashimoto S
    Biotechnol Lett; 2004 Oct; 26(19):1487-91. PubMed ID: 15604784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-expression of recombinant nucleoside phosphorylase from Escherichia coli and its application.
    Ge C; OuYang L; Ding Q; Ou L
    Appl Biochem Biotechnol; 2009 Oct; 159(1):168-77. PubMed ID: 19099210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant protein production in an Escherichia coli reduced genome strain.
    Sharma SS; Blattner FR; Harcum SW
    Metab Eng; 2007 Mar; 9(2):133-41. PubMed ID: 17126054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-tyrosine production by deregulated strains of Escherichia coli.
    Lütke-Eversloh T; Stephanopoulos G
    Appl Microbiol Biotechnol; 2007 May; 75(1):103-10. PubMed ID: 17221195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for conditions of enhanced production of a recombinant beta-glucanase secreted into the medium by Escherichia coli.
    Spexard M; Beshay U; Risse JM; Miksch G; Flaschel E
    Biotechnol Lett; 2010 Feb; 32(2):243-8. PubMed ID: 19816658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-yield anthocyanin biosynthesis in engineered Escherichia coli.
    Yan Y; Li Z; Koffas MA
    Biotechnol Bioeng; 2008 May; 100(1):126-40. PubMed ID: 18023053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designing an inducer-feeding schedule to enhance production of recombinant protein in Escherichia coli by microbial reaction engineering.
    Gonzalez JM; Hsu JT
    Biotechnol Prog; 2008; 24(3):667-74. PubMed ID: 18459729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineering cell physiology to enhance recombinant protein production in Escherichia coli.
    Chou CP
    Appl Microbiol Biotechnol; 2007 Sep; 76(3):521-32. PubMed ID: 17571257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of the expression of hepatitis B virus e gene in Pichia pastoris and immunological characterization of the product.
    Li Z; Hong G; Wu Z; Hu B; Xu J; Li L
    J Biotechnol; 2008 Nov; 138(1-2):1-8. PubMed ID: 18721834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.